Synthetic and Medicinal Perspective of 1,2,4-Triazole as Anticancer Agents
- PMID: 36226542
- DOI: 10.1002/cbdv.202200679
Synthetic and Medicinal Perspective of 1,2,4-Triazole as Anticancer Agents
Abstract
Cancer is still one of the leading causes of death worldwide. Many researchers are working to design and develop heterocyclic-based drugs with the potential to treat cancer at various stages. There is always an unmet need to discover new anticancer drugs to treat different types of cancer. Based on literature reports, it was evident that hybrid 1,2,4-triazoles exhibit a wide spectrum of biological potential (particularly potent anticancer activity), as compared to the corresponding monocyclic compounds. In this review, we summarized fused/hybrid 1,2,4-triazole and poly-functionalized 1,2,4-triazoles as anticancer agents. Triazole may be fused with other heterocyclic scaffolds like pyrimidine, pyridine, piperidine, quinoxaline, quinazoline, thiadiazine, indole, phthalazine etc. A clear explanation of the method of synthesis, structure-activity relationship, and in vitro results plus the inhibitory concentration of new molecules are focused on in this review article.
Keywords: 1,2,4-triazole; anticancer; cytotoxicity; heterocycles; structure-activity relationship.
© 2022 Wiley-VHCA AG, Zurich, Switzerland.
References
-
- B. Karami, M. Farahi, Z. Banaki, ‘A New Protocol for Catalyst-Free Regioselective Synthesis Of 5, 9-Dihydropyrimido [5, 4-E] [1, 2, 4] Triazolo [1, 5-A] Pyrimidine-6, 8 (4H, 7H)-Diones’, Synlett. 2015, 26, 741-744.
-
- F. H. Al-Ostoot, M. Al-Ghorbani, S. A. Khanum, ‘Recent Investigation on Heterocycles with One Nitrogen [Piperidine, Pyridine and Quinoline], Two Nitrogen [1, 3, 4-Thiadiazole and Pyrazole] and Three Nitrogen [1, 2, 4-Triazole]: A Review’, J. Iran. Chem. Soc. 2022, 19,23-54.
-
- R. Aggarwal, G. Sumran, ‘An Insight on Medicinal Attributes Of 1, 2, 4-Triazoles’, Eur. J. Med. Chem. 2020, 205, 112652.
-
- R. Sathyanarayana, B. Poojary, ‘Exploring Recent Developments On 1, 2, 4-Triazole: Synthesis and Biological Applications’, J. Chin. Chem. Soc. 2020, 67, 459-477.
-
- M. V. Slivka, N. I. Korol, M. M. Fizer, ‘Fused Bicyclic 1, 2, 4-Triazoles with One Extra Sulfur Atom: Synthesis, Properties, and Biological Activity’, J. Heterocycl. Chem. 2020, 57, 3236-3254.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical